Beijing Leadman Biochemistry Co Ltd (300289) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.89 Million ≈ $1.74 Million USD) by net assets (CN¥1.71 Billion ≈ $250.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300289 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Beijing Leadman Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Leadman Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Eniro AB ST:ENRO	0.028x
Anhui Xinli Finance Co Ltd SHG:600318	0.060x
Imricor Medical Systems Inc AU:IMR	-0.853x
Pansoft Company Limited SHE:300996	N/A
Beijing Centergate Technologies Holding Co Ltd SHE:000931	0.001x
Jiangsu Jiuwu Hi-Tech Co Ltd SHE:300631	0.064x
Lutian Machinery Co Ltd SHG:605259	-0.005x
iHeartMedia Inc Class A NASDAQ:IHRT	0.048x

Annual Cash Flow Conversion Efficiency for Beijing Leadman Biochemistry Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 300289 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.67 Billion ≈ $244.48 Million	CN¥29.16 Million ≈ $4.27 Million	0.017x	-51.93%
2024-12-31	CN¥1.72 Billion ≈ $251.48 Million	CN¥62.41 Million ≈ $9.13 Million	0.036x	-51.25%
2023-12-31	CN¥1.80 Billion ≈ $264.07 Million	CN¥134.42 Million ≈ $19.67 Million	0.074x	+21.74%
2022-12-31	CN¥1.78 Billion ≈ $260.54 Million	CN¥108.93 Million ≈ $15.94 Million	0.061x	+1.65%
2021-12-31	CN¥1.98 Billion ≈ $289.46 Million	CN¥119.06 Million ≈ $17.42 Million	0.060x	-38.79%
2020-12-31	CN¥1.38 Billion ≈ $201.75 Million	CN¥135.56 Million ≈ $19.84 Million	0.098x	+14.38%
2019-12-31	CN¥1.45 Billion ≈ $212.18 Million	CN¥124.65 Million ≈ $18.24 Million	0.086x	+52.52%
2018-12-31	CN¥1.44 Billion ≈ $210.34 Million	CN¥81.02 Million ≈ $11.86 Million	0.056x	-33.59%
2017-12-31	CN¥1.43 Billion ≈ $208.55 Million	CN¥120.97 Million ≈ $17.70 Million	0.085x	+38.74%
2016-12-31	CN¥1.34 Billion ≈ $195.60 Million	CN¥81.78 Million ≈ $11.97 Million	0.061x	-56.65%
2015-12-31	CN¥1.26 Billion ≈ $184.37 Million	CN¥177.82 Million ≈ $26.02 Million	0.141x	+1267.55%
2014-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥-13.21 Million ≈ $-1.93 Million	-0.012x	-111.38%
2013-12-31	CN¥851.12 Million ≈ $124.55 Million	CN¥90.45 Million ≈ $13.24 Million	0.106x	+39.78%
2012-12-31	CN¥761.02 Million ≈ $111.36 Million	CN¥57.86 Million ≈ $8.47 Million	0.076x	-42.81%
2011-12-31	CN¥220.77 Million ≈ $32.31 Million	CN¥29.34 Million ≈ $4.29 Million	0.133x	-60.29%
2010-12-31	CN¥159.72 Million ≈ $23.37 Million	CN¥53.46 Million ≈ $7.82 Million	0.335x	+12.77%
2009-12-31	CN¥105.32 Million ≈ $15.41 Million	CN¥31.26 Million ≈ $4.57 Million	0.297x	+13.30%
2008-12-31	CN¥83.90 Million ≈ $12.28 Million	CN¥21.98 Million ≈ $3.22 Million	0.262x	--

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices

Market Cap

$467.29 Million

CN¥3.19 Billion CNY

Market Cap Rank

#12761 Global

#3779 in China

Share Price

CN¥5.87

Change (1 day)

+0.17%

52-Week Range

CN¥4.99 - CN¥11.33

All Time High

CN¥23.05